Galil Genetic Analysis recently began offering its OncoGenetics RDMGGA 1.0 Re-sequencing Chip as a service to its customers in Israel, according to the company's CEO.
The partnership is one of several for TessArae, which has traditionally served the infectious disease-testing market, but has recently begun offering services to genetic disease-testing firms.
CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.
In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.
